Professional
Added to YB: 2026-09-17
Pitch date: 2026-07-16
ZTS [bullish]
Zoetis Inc.
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$30.4B
Pitch Price
N/A
Price Target
N/A
Dividend
2.88%
EV/EBITDA
9.08
P/E
12.02
EV/Sales
3.99
Sector
Pharmaceuticals
Category
value
Moon Capital Management New Portfolio Holding: Zoetis Inc.
ZTS: Zoetis, the world’s largest pure-play animal-health company, was purchased around $73.20 at less than 11x earnings versus above 30x for much of the past decade. Slower companion-animal growth is viewed as a temporary product-cycle issue rather than franchise impairment, while durable veterinarian relationships, long product lifecycles and a strong pipeline support long-term earnings power. Risks are persistent competition, pipeline disappointments and a delayed companion-animal recovery.
Read full article (3 min)